NEWS
AMIVAS Launches Europe’s First & Only Licensed Severe Malaria Treatment
AMIVAS Ireland Ltd (AMIVAS), a biopharmaceutical company focused on developing, commercialising, manufacturing and distributing artesunate for the treatment of severe malaria, today announced the launch of Artesunate AMIVAS in Europe and the U.K.
AMIVAS IRELAND LTD. RECEIVES MHRA AUTHORISATION FOR UK
AMIVAS Ireland Ltd. Receives Authorisation from the Medicines & Healthcare Products Regulatory Agency (MHRA) to Market Artesunate Amivas (artesunate) in the UK for Initial Treatment of Severe Malaria